Automated description from the Alliance of Genome Resources
Predicted to have ATPase activity; chromatin binding activity; and histone binding activity. Predicted to be involved in negative regulation of chromatin silencing and positive regulation of transcription by RNA polymerase II. Predicted to localize to the nucleoplasm. Is expressed in several structures, including brain ventricular layer; early conceptus; gonad; spleen; and uterus. Orthologous to human ATAD2 (ATPase family AAA domain containing 2).